.
MergerLinks Header Logo

New Deal


Announced

CD&R and TPG to acquire the remaining shares in Covetrus for $3bn.

Financials

Edit Data
Transaction Value£2,462m
Consideration TypeCash
Capital Owned24%
Capital Bid For76%
EV/Sales0.9x
EV/EBITDA16.39x
Share Price Premium39%
One Off Charge-

Tags

Edit

United States

application software

Friendly

Public

Pending

Majority

Single Bidder

Private Equity

Acquisition

Domestic

Health Care Services

Synopsis

Edit

Private equity firms Clayton, Dubilier & Rice and TPG Capital agreed to acquire the remaining shares in Covetrus, an American company providing animal health products and related services, for $3bn. "Our Board and management team are currently reviewing the offer as we look for ways to help Covetrus continue to grow and better serve our customers, employees, suppliers, business partners and shareholders. There can be no assurance that any transaction will be consummated, but regardless of the ultimate outcome, this is a vote of confidence in our future from our largest shareholder, CD&R. As always, we remain focused on empowering veterinarians and driving better care for animals across the globe," Covetrus.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US